A team of Bangladeshi doctors claims that their research on the combination of two widely used drugs has yielded “astounding” results in curing patients with acute symptoms of the coronavirus.
Dr. Tarek Alam, Head of Bangladesh Medical College Hospital, a senior member of the medical team said that a frequently used antiprotozoal medicine called Ivermectin in a single dose with Doxycycline, an antibiotic yielded virtually near-miraculous result in curing the patients with COVID-19.
Alam’s associate Dr Rabiul Morshed said despite being a non-COVID-19 facility a huge number of patients “directly and indirectly end up in BMCH, the country’s premier private general hospital.
“But all of them have shown remarkable recovery being (COVID-19) negative in four days and 50% reduction of symptoms in 3 days," he said.
“We have got astounding results. Out of 60 COVID-19 patients, all recovered as the combination of the two drugs were applied. My team was prescribing the two medicines only for coronavirus patients, most of them initially reporting with respiratory problems with related complaints, later to be tested COVID-19 positive,” he said.
He added there were no side effects of the combination and the patients also recovered within four days.
“The repeated or second tests, in line with the procedure, reconfirmed them COVID-19 negative in all the cases under the research which found the combination to have no side effects on patients either,” he said.
The team has reportedly contacted the concerned government regulators and is preparing to conduct international procedures for the acknowledgement of the drugs for treating COVID-19 patients.
Bangladesh has so far reported 20,995 cases and a total of 314 people have lost their lives due to the disease. The first case of coronavirus in Bangladesh was reported in the crowded camps for Rohingya refugees in southern Bangladesh, where more than 1 million refugees are sheltered.
As on 16th May, 2020, COVID-19 confirmed cases are being reported from 214 countries/territories/areas. A total of 42,48,389 laboratory confirmed cases and 2,92,046 deaths have been reported globally. Focus of outbreak that was initially China, has now shifted toEuropean region and United States of America.Maximum number of cases is currently being reported from USA, Russia, Spain, UK, Italy,Germany, Brazil, Turkey and France.As per analysis of the biggest cohort reported by Chinese CDC, about 81% of the cases are mild,14% require hospitalization and 5% require ventilator and critical care management.